693 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Donald Trump's Nominee for HHS Secretary Causes a Tumble in Biotech Stocks https://www.fool.com/investing/2017/11/14/biopharma-stocks-tumble-on-fear-of-price-scrutiny.aspx?source=iedfolrf0000001 Nov 14, 2017 - Worry whether drug pricing will return to the forefront in Washington, D.C. is increasing following Donald Trump's nomination of a drug-industry insider as his next Department of Health and Human Services secretary.
Novo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day http://www.zacks.com/stock/news/282791/novo-nordisk-4-other-pharma-stocks-in-focus-on-world-diabetes-day?cid=CS-ZC-FT-282791 Nov 14, 2017 - Despite pricing pressure & competition, the diabetes market remains lucrative given the prevalence of the disease and demand for better treatments. Novo Nordisk (NVO) is a key player in this market.
Why Nektar Therapeutics Shares Are Rallying 13.8% Today https://www.fool.com/investing/2017/11/13/why-nektar-therapeutics-shares-are-rallying-138-to.aspx?source=iedfolrf0000001 Nov 13, 2017 - Encouraging results for one of its drugs in solid tumor cancers are sparking interest in the clinical-stage company.
3 Biotech Stocks That Soared This Week: Are They Buys? https://www.fool.com/investing/2017/11/11/3-biotech-stocks-that-soared-this-week-are-they-bu.aspx?source=iedfolrf0000001 Nov 11, 2017 - Nektar, Sage, and Valeant stocks ranked among the biggest winners this week. But will their winning ways continue?
Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod http://www.zacks.com/stock/news/282524/pharma-stock-roundup-astrazenecas-q3-earnings-roche-merck-drugs-get-fda-nod?cid=CS-ZC-FT-282524 Nov 10, 2017 - Key highlights this week include AstraZeneca's (AZN) Q3 results and the FDA approval of the first new CMV medicine in 15 years.
Pharma ETFs Down Post Q3 Earnings http://www.zacks.com/stock/news/282412/pharma-etfs-down-post-q3-earnings?cid=CS-ZC-FT-282412 Nov 09, 2017 - The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.
Why Nektar Therapeutics Shares Are Soaring 13% Higher https://www.fool.com/investing/2017/11/08/why-nektar-therapeutics-shares-are-soaring-107-hig.aspx?source=iedfolrf0000001 Nov 08, 2017 - Third-quarter financial results that impressed kindled investor enthusiasm.
Celldex (CLDX) Q3 Loss Narrows, Revenues Beat, Shares Up http://www.zacks.com/stock/news/282227/celldex-cldx-q3-loss-narrows-revenues-beat-shares-up?cid=CS-ZC-FT-282227 Nov 08, 2017 - Celldex Therapeutics, Inc. (CLDX) reported narrower-than-expected loss in Q3 and also beat estimates for sales. Shares rose in after-hours trading on Tuesday.
Novo Nordisk A/S Slogs Through the Year https://www.fool.com/investing/2017/11/07/novo-nordisk-as-slogs-through-the-year.aspx?source=iedfolrf0000001 Nov 07, 2017 - It was another lackluster quarter from the diabetes specialist.
The 3 Best Diabetes Stocks to Buy in 2018 https://www.fool.com/investing/2017/10/30/the-3-best-diabetes-stocks-to-buy-in-2018.aspx?source=iedfolrf0000001 Oct 30, 2017 - Not all diabetes stocks are created equally.

Pages: 1...4950515253545556575859...70

<<<Page 54>